{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T05:14:51Z","timestamp":1733375691758,"version":"3.30.1"},"reference-count":24,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2024.0212","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T06:49:37Z","timestamp":1733294977000},"source":"Crossref","is-referenced-by-count":0,"title":["Pretreatment with unfractionated heparin in ST-elevation myocardial infarction"],"prefix":"10.3238","author":[{"given":"Sascha","family":"Macherey-Meyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Heyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max Maria","family":"Meertens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Finke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Ahrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank Michael","family":"Baer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Eberhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Horlitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Malte","family":"Sinning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Rosswinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Baldus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"10.3238\/arztebl.m2024.0212_ref1","doi-asserted-by":"crossref","unstructured":"Byrne RA, Rossello X, Coughlan JJ, et al.: 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023; 44: 3720\u2013826.","DOI":"10.1093\/eurheartj\/ehad191"},{"key":"10.3238\/arztebl.m2024.0212_ref2","doi-asserted-by":"crossref","unstructured":"Ibanez B, James S, Agewall S, et al.: 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39: 119\u201377.","DOI":"10.1093\/eurheartj\/ehx393"},{"key":"10.3238\/arztebl.m2024.0212_ref3","unstructured":"O\u2018Gara PT, Kushner FG, Ascheim DD, et al.: 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127: e362\u2013425."},{"key":"10.3238\/arztebl.m2024.0212_ref4","doi-asserted-by":"crossref","unstructured":"Karlsson S, Andell P, Mohammad MA, et al.: Editor\u2018s Choice- Heparin pre-treatment in patients with ST-segment elevation myocardial infarction and the risk of intracoronary thrombus and total vessel occlusion. Insights from the TASTE trial. Eur Heart J Acute Cardiovasc Care 2019; 8: 15\u201323.","DOI":"10.1177\/2048872617727723"},{"key":"10.3238\/arztebl.m2024.0212_ref5","doi-asserted-by":"crossref","unstructured":"Emilsson OL, Bergman S, Mohammad MA, et al.: Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). EuroIntervention 2022; 18: 709\u201318.","DOI":"10.4244\/EIJ-D-22-00432"},{"key":"10.3238\/arztebl.m2024.0212_ref6","doi-asserted-by":"crossref","unstructured":"Bloom JE, Andrew E, Nehme Z, et al.: Pre-hospital heparin use for ST-elevation myocardial infarction is safe and improves angiographic outcomes. Eur Heart J Acute Cardiovasc Care 2021; 10: 1140\u20137.","DOI":"10.1093\/ehjacc\/zuab032"},{"key":"10.3238\/arztebl.m2024.0212_ref7","doi-asserted-by":"crossref","unstructured":"Macherey S, Meertens MM, Adler C, et al.: Impact of respiratory infectious epidemics on STEMI incidence and care. Sci Rep 2021; 11: 23066.","DOI":"10.1038\/s41598-021-02480-z"},{"key":"10.3238\/arztebl.m2024.0212_ref8","doi-asserted-by":"crossref","unstructured":"Pfister R, Lee S, Kuhr K, et al.: Impact of the type of first medical contact within a guideline-conform ST-elevation myocardial infarction network: a prospective observational registry study. PLoS One 2016; 11: e0156769.","DOI":"10.1371\/journal.pone.0156769"},{"key":"10.3238\/arztebl.m2024.0212_ref9","doi-asserted-by":"crossref","unstructured":"Flesch M, Hagemeister J, Berger HJ, et al.: Implementation of guidelines for the treatment of acute ST-elevation myocardial infarction: the Cologne Infarction Model Registry. Circ Cardiovasc Interv 2008; 1: 95\u2013102.","DOI":"10.1161\/CIRCINTERVENTIONS.108.768176"},{"key":"10.3238\/arztebl.m2024.0212_ref10","doi-asserted-by":"crossref","unstructured":"Hamm CW, Schneck E, Buerke M, et al.: Empfehlungen zur pr\u00e4hospitalen Behandlung des akuten Koronarsyndroms bei Patienten unter Dauertherapie mit neuen oralen Antikoagulanzien (NOAKs). Der Kardiologe 2021; 15: 32\u20137.","DOI":"10.1007\/s12181-020-00439-4"},{"key":"10.3238\/arztebl.m2024.0212_ref11","doi-asserted-by":"crossref","unstructured":"TIMI Study Group: The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med 1985; 312: 932\u20136.","DOI":"10.1056\/NEJM198504043121437"},{"key":"10.3238\/arztebl.m2024.0212_ref12","doi-asserted-by":"crossref","unstructured":"Turer AT, Mahaffey KW, Gallup D, et al.: Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction. Curr Control Trials Cardiovasc Med 2005; 6: 12.","DOI":"10.1186\/1468-6708-6-12"},{"key":"10.3238\/arztebl.m2024.0212_ref13","doi-asserted-by":"crossref","unstructured":"Macherey-Meyer S, Braumann S, Heyne S, et al.: [Preclinical loading in patients with acute chest pain and acute coronary syndrome\u2014PRELOAD survey]. Med Klin Intensivmed Notfmed 2024; 119: 529\u201337.","DOI":"10.1007\/s00063-023-01087-8"},{"key":"10.3238\/arztebl.m2024.0212_ref14","doi-asserted-by":"crossref","unstructured":"Macherey-Meyer S, Heyne S, Meertens MM, et al.: Outcome of out-of-hospital cardiac arrest patients stratified by pre-clinical loading with Aspirin and Heparin: a retrospective cohort analysis. J Clin Med 2023; 12: 3817.","DOI":"10.3390\/jcm12113817"},{"key":"10.3238\/arztebl.m2024.0212_ref15","doi-asserted-by":"crossref","unstructured":"Montalescot G, Zeymer U, Silvain J, et al.: Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. Lancet 2011; 378: 693\u2013703.","DOI":"10.1016\/S0140-6736(11)60876-3"},{"key":"10.3238\/arztebl.m2024.0212_ref16","doi-asserted-by":"crossref","unstructured":"Collet JP, Zeitouni M: Heparin pretreatment in STEMI: is earlier always better? EuroIntervention 2022; 18: 697\u20139.","DOI":"10.4244\/EIJ-E-22-00035"},{"key":"10.3238\/arztebl.m2024.0212_ref17","doi-asserted-by":"crossref","unstructured":"Zijlstra F, Ernst N, de Boer MJ, et al.: Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction. J Am Coll Cardiol 2002; 39: 1733\u20137.","DOI":"10.1016\/S0735-1097(02)01856-9"},{"key":"10.3238\/arztebl.m2024.0212_ref18","doi-asserted-by":"crossref","unstructured":"McGinley C, Mordi IR, Kell P, et al.: Prehospital administration of unfractionated Heparin in ST-segment elevation myocardial infarction is associated with improved long-term survival. J Cardiovasc Pharmacol 2020; 76: 159\u201363.","DOI":"10.1097\/FJC.0000000000000865"},{"key":"10.3238\/arztebl.m2024.0212_ref19","doi-asserted-by":"crossref","unstructured":"Stone GW, Cox D, Garcia E, et al.: Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation 2001; 104: 636\u201341.","DOI":"10.1161\/hc3101.093701"},{"key":"10.3238\/arztebl.m2024.0212_ref20","doi-asserted-by":"crossref","unstructured":"Chung WY, Han MJ, Cho YS, et al.: Effects of the early administration of heparin in patients with ST-elevation myocardial infarction treated by primary angioplasty. Circ J 2007; 71: 862\u20137.","DOI":"10.1253\/circj.71.862"},{"key":"10.3238\/arztebl.m2024.0212_ref21","doi-asserted-by":"crossref","unstructured":"Giralt T, Carrillo X, Rodriguez-Leor O, et al.: Time-dependent effects of unfractionated heparin in patients with ST-elevation myocardial infarction transferred for primary angioplasty. Int J Cardiol 2015; 198: 70\u20134.","DOI":"10.1016\/j.ijcard.2015.06.009"},{"key":"10.3238\/arztebl.m2024.0212_ref22","doi-asserted-by":"crossref","unstructured":"Kammler J, Kypta A, Hofmann R, et al.: TIMI 3 flow after primary angioplasty is an important predictor for outcome in patients with acute myocardial infarction. Clin Res Cardiol 2009; 98: 165\u201370.","DOI":"10.1007\/s00392-008-0735-9"},{"key":"10.3238\/arztebl.m2024.0212_ref23","doi-asserted-by":"crossref","unstructured":"Scholz P, Friede T, Scholz KH, Grabmaier U, Meyer T, Seidler T: Pre-hospital heparin is not associated with infarct vessel patency and mortality in ST-segment elevation myocardial infarction patients with out-of-hospital cardiac arrest. Clin Res Cardiol 2024; DOI: 10.1007\/s00392\u2013024\u201302499-y. Online ahead of print.","DOI":"10.1007\/s00392-024-02499-y"},{"key":"10.3238\/arztebl.m2024.0212_ref24","doi-asserted-by":"crossref","unstructured":"Liem A, Zijlstra F, Ottervanger JP, et al.: High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial. J Am Coll Cardiol 2000; 35: 600\u20134.","DOI":"10.1016\/S0735-1097(99)00597-5"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T06:50:03Z","timestamp":1733295003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":24,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2024.0212","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]}}}